NEXGEL, INC. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NEXGEL, INC. stock issued during period, value, other for the quarter ending 2024-09-30 was $1.00M.
- NEXGEL, INC. stock issued during period, value, other for the quarter ending 2024-03-31 was $946.00K.
- NEXGEL, INC. stock issued during period, value, other for fiscal 2025 was $963.00K, a 74.47% decline from fiscal 2024.
- NEXGEL, INC. stock issued during period, value, other for fiscal 2024 was $3.77M.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2025-12-31 | $963.00K 10-K · filed 2026-03-31 | |
| 2024-12-31 | $3.77M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $1.00M 10-Q · filed 2024-11-13 | |
| 2024-03-31 | $946.00K 10-Q · filed 2025-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |